Top Markets
Coin of the day
MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc.

MYMD
Kedudukan dalam Saham #35400
MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical... MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is advancing Supera-CBD, a synthetic version of cannabidiol, which aims to address chronic pain, addiction, and epilepsy. MyMD Pharmaceuticals was established in 2014 and its corporate headquarters are situated in Baltimore, Maryland.
Harga Saham
$1.85
Disegerakkan terakhir: 2024-08-19
Modal Pasaran
$3.96M
Perubahan (1 hari)
2.78%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan MyMD Pharmaceuticals, Inc. (MYMD)

Kategori

Sejarah harga saham bagi MyMD Pharmaceuticals, Inc. (MYMD)
Harga penutupan tertinggi: $1.83 pada 2024-08-01

Harga penutupan terendah: $120.01K pada 2014-01-01
Sejarah harga saham MyMD Pharmaceuticals, Inc. dari 2014 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2024 -76.01%
2023 -82.01%
2022 -78.21%
2021 60.05%
2020 -42.41%
2019 -86.46%
2018 -78.63%
2017 -81.85%
2016 23.71%
2015 -54.94%
2014 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE